Altree-Tacha, D., Tyrrell, J., & Haas, T. (2017). CDH17 Is a More Sensitive Marker for Gastric Adenocarcinoma Than CK20 and CDX2. Archives of pathology & laboratory medicine (1976), 141(1), 144-150. https://doi.org/10.5858/arpa.2015-0404-OA
Chicago-Zitierstil (17. Ausg.)Altree-Tacha, David, Jillian Tyrrell, und Thomas Haas. "CDH17 Is a More Sensitive Marker for Gastric Adenocarcinoma Than CK20 and CDX2." Archives of Pathology & Laboratory Medicine (1976) 141, no. 1 (2017): 144-150. https://doi.org/10.5858/arpa.2015-0404-OA.
MLA-Zitierstil (9. Ausg.)Altree-Tacha, David, et al. "CDH17 Is a More Sensitive Marker for Gastric Adenocarcinoma Than CK20 and CDX2." Archives of Pathology & Laboratory Medicine (1976), vol. 141, no. 1, 2017, pp. 144-150, https://doi.org/10.5858/arpa.2015-0404-OA.